“Submission... restarted using a retrospective EHR and lab data set... provided longitudinal follow-up of about three years and resulted in a successful approval”
♫
Said on FDA Watch
FDA Watch · The Rise of Real-World Evidence in Regulatory Strategy, Part 2: RWE in Medical Devices
Audio streams from the publisher’s own feed. Verbatim does not host or copy it.
ran a pre-market regulatory submission for a thermal ablation catheter using EHR data from two health systems covering over 1,400 patients
1,400 patients
“Submission... restarted using a retrospective EHR and lab data set... provided longitudinal follow-up of about three years and resulted in a successful approval”
“They're using de-identified patient data, we're going to be tracking to see whether doing these whole body MRIs actually improve health outcomes down the line”
“We just signed our 31st health system. We're in 13 states and two countries... white-labeled... gives these health systems the same sort of tech-enabled logistics experience.”
“We have a system where we have two SMEs right now, including myself. We stay on top of this to make sure that all of our regulatory requirements are aligned with what's present.”
The strongest new moments on your topics, in the speakers' own words. Free for three topics.
No card. No password. One-click unsubscribe.
Pro watches up to 25 names or phrases and emails you the morning after they are said.
See Pro, $29 a monthVerbatim quotes a short extract and links to the episode; the episode belongs to its publisher. Remove a show.